Carbon Nanotubes as Versatile Devices for Detoxification and Cellular Entry
dc.comment.hidden | SPRINGER LICENSE TERMS AND CONDITIONS Oct 29, 2012 This is a License Agreement between David Donkor ("You") and Springer ("Springer") provided by Copyright Clearance Center ("CCC"). The license consists of your order details, the terms and conditions provided by Springer, and the payment terms and conditions. All payments must be made in full to CCC. For payment instructions, please see information listed at the bottom of this form. License Number 3016531449747 License date Oct 26, 2012 Licensed content publisher Springer Licensed content publication Nano Research Licensed content title Carbon nanotubes inhibit the hemolytic activity of the pore-forming toxin pyolysin Licensed content author Apraku David Donkor Licensed content date Jan 1, 2009 Volume number 2 Issue number 7 Type of Use Thesis/Dissertation Portion Full text Number of copies 1 Author of this Springer article Yes and you are the sole author of the new work Order reference number None Title of your thesis / dissertation Carbon Nanotubes as Versatile Devices for Detoxification and Cellular Entry Expected completion date Oct 2012 Estimated size(pages) 132 Total 0.00 CAD Terms and Conditions Introduction The publisher for this copyrighted material is Springer Science + Business Media. By clicking "accept" in connection with completing this licensing transaction, you agree that the following terms and conditions apply to this transaction (along with the Billing and Payment terms and conditions established by Copyright Clearance Center, Inc. ("CCC"), at the time that you opened your Rightslink account and that are available at any time at http://myaccount.copyright.com). Limited License With reference to your request to reprint in your thesis material on which Springer Science and Business Media control the copyright, permission is granted, free of charge, for the use indicated in your enquiry. Licenses are for one-time use only with a maximum distribution equal to the number that you identified in the licensing process. This License includes use in an electronic form, provided its password protected or on the university’s intranet or repository, including UMI (according to the definition at the Sherpa website: http://www.sherpa.ac.uk/romeo/). For any other electronic use, please contact Springer at (permissions.dordrecht@springer.com or permissions.heidelberg@springer.com). The material can only be used for the purpose of defending your thesis, and with a maximum of 100 extra copies in paper. Although Springer controls copyright to the material and is entitled to negotiate on rights, this license is only valid, provided permission is also obtained from the (co) author (address is given with the article/chapter) and provided it concerns original material which does not carry references to other sources (if material in question appears with credit to another source, authorization from that source is required as well). Permission free of charge on this occasion does not prejudice any rights we might have to charge for reproduction of our copyrighted material in the future. Altering/Modifying Material: Not Permitted You may not alter or modify the material in any manner. Abbreviations, additions, deletions and/or any other alterations shall be made only with prior written authorization of the author(s) and/or Springer Science + Business Media. (Please contact Springer at (permissions.dordrecht@springer.com or permissions.heidelberg@springer.com) Reservation of Rights Springer Science + Business Media reserves all rights not specifically granted in the combination of (i) the license details provided by you and accepted in the course of this licensing transaction, (ii) these terms and conditions and (iii) CCC's Billing and Payment terms and conditions. Copyright Notice:Disclaimer You must include the following copyright and permission notice in connection with any reproduction of the licensed material: "Springer and the original publisher /journal title, volume, year of publication, page, chapter/article title, name(s) of author(s), figure number(s), original copyright notice) is given to the publication in which the material was originally published, by adding; with kind permission from Springer Science and Business Media" Warranties: None Example 1: Springer Science + Business Media makes no representations or warranties with respect to the licensed material. Example 2: Springer Science + Business Media makes no representations or warranties with respect to the licensed material and adopts on its own behalf the limitations and disclaimers established by CCC on its behalf in its Billing and Payment terms and conditions for this licensing transaction. Indemnity You hereby indemnify and agree to hold harmless Springer Science + Business Media and CCC, and their respective officers, directors, employees and agents, from and against any and all claims arising out of your use of the licensed material other than as specifically authorized pursuant to this license. No Transfer of License This license is personal to you and may not be sublicensed, assigned, or transferred by you to any other person without Springer Science + Business Media's written permission. No Amendment Except in Writing This license may not be amended except in a writing signed by both parties (or, in the case of Springer Science + Business Media, by CCC on Springer Science + Business Media's behalf). Objection to Contrary Terms Springer Science + Business Media hereby objects to any terms contained in any purchase order, acknowledgment, check endorsement or other writing prepared by you, which terms are inconsistent with these terms and conditions or CCC's Billing and Payment terms and conditions. These terms and conditions, together with CCC's Billing and Payment terms and conditions (which are incorporated herein), comprise the entire agreement between you and Springer Science + Business Media (and CCC) concerning this licensing transaction. In the event of any conflict between your obligations established by these terms and conditions and those established by CCC's Billing and Payment terms and conditions, these terms and conditions shall control. Jurisdiction All disputes that may arise in connection with this present License, or the breach thereof, shall be settled exclusively by arbitration, to be held in The Netherlands, in accordance with Dutch law, and to be conducted under the Rules of the 'Netherlands Arbitrage Instituut' (Netherlands Institute of Arbitration).OR: All disputes that may arise in connection with this present License, or the breach thereof, shall be settled exclusively by arbitration, to be held in the Federal Republic of Germany, in accordance with German law. Other terms and conditions: v1.3 If you would like to pay for this license now, please remit this license along with your payment made payable to "COPYRIGHT CLEARANCE CENTER" otherwise you will be invoiced within 48 hours of the license date. Payment should be in the form of a check or money order referencing your account number and this invoice number RLNK500885105. Once you receive your invoice for this order, you may pay your invoice by credit card. Please follow instructions provided at that time. Make Payment To: Copyright Clearance Center Dept 001 P.O. Box 843006 Boston, MA 02284-3006 For suggestions or comments regarding this order, contact RightsLink Customer Support: customercare@copyright.com or +1-877-622-5543 (toll free in the US) or +1-978-646-2777. Gratis licenses (referencing $0 in the Total field) are free. Please retain this printable license for your reference. No payment is required. | en |
dc.contributor.author | Donkor, David Apraku | |
dc.date.accessioned | 2012-10-30T19:26:53Z | |
dc.date.available | 2014-06-27T05:00:29Z | |
dc.date.issued | 2012-10-30T19:26:53Z | |
dc.date.submitted | 2012 | |
dc.description.abstract | The ability to bypass most cellular barriers to gain access to intracellular compartments has great potential in cell biology. The possibilities range from efficient delivery of macromolecules such as plasmids to small proteins and oligonucleotides that are sensitive to degradation. In biomedicine, easy access means enhanced cellular imaging and delivery of many therapeutics currently hampered by poor stability and cellular uptake. Carbon Nanotubes (CNTs) are attractive in these applications due to their efficient cellular uptake. While mode of entry of CNTs into cells is debatable, possibly their natural shape allows for their selective penetration across biological barriers in a non-destructive way, making them versatile as membrane permeating particles. The present study explores the diverse functionalities of CNTs including: 1) Efficient delivery of DNA into HeLa cells using vertically aligned MWNT arrays, 2) The use of Single Walled Carbon Nanotubes (SWNTs) as nano detoxifiers and 3) the design of SWNTs for efficient cellular uptake. Generally, vertically aligned nanoneedles have been used to influence the behavior and differentiation of various cell types. In the first work described in chapter 2, periodic high-density array MWNT nanoneedles is shown to support cell growth and penetrate into HeLa cells, making it ideal for use in cellular imaging and the efficient delivery of plasmid DNA into cells. Most importantly, we show that transfection with the MWNT substrate exhibited more uniformity in comparison to the commercially available lipofection procedure. Lipofection involves the formation of a complex of DNA and cationic lipids that interact with the cell via electrostatic interactions, leading to internalization, DNA escape into the cytosol, and the eventual transport into the nucleus. Functionalized CNTS have demonstrated great biocompatibility and potential for drug delivery in vitro. In the work described in chapter 3, we synthesized acid-oxidized and non-covalently PEGlyated SWNTs, which were reported previously for drug delivery purposes, and explored their potential for detoxification in the bloodstream. We investigated the binding of SWNTs to a pore-forming toxin pyolysin. The SWNTs were found to prevent toxin-induced pore formation in the cell membrane of human red blood cells. Quantitative hemolysis assay and scanning electron microscopy were used to evaluate the inhibition of hemolytic activity of pyolysin. Unlike HeLa cells, human red blood cells did not internalize oxidized SWNTs according to Raman spectroscopy data. Molecular modeling and circular dichroism measurements were used to predict the 3D structure of pyolysin (domain 4) and its interaction with SWNTs. The Tryptophan-rich hydrophobic motif in the membrane-binding domain of pyolysin, a common construct in a large family of cholesterol-dependent cytolysins (CDCs), showed high affinity for SWNTs. In the final two chapters, chapters 4 and 5, we focused on shorter CNTs (<70 nm) that have less length variations. This enabled the determination of several length related characteristics such as cellular uptake and distribution of SWNTs within between cells. Here, cellular uptake of two water-soluble SWNTs, Short SWNTs (S_SWNTs) and Ultra-Short SWNTs (US_SWNTs), was evaluated against various mammalian cells. Cellular entry of S_SWNTs (chapter 4), similar in dimensions to those reported in the literature, is shown to be affected by their hydrophilic corona and exhibit time-dependent nuclear accumulation. In contrast, US_SWNTs show no dependence of cellular entry on their hydrophilic exterior (chapter 5). Furthermore, intracellular localization and excretion of the US_SWNTs is observed to be cell type-dependent. Results presented in this work show the potential of CNTs as nano detoxifiers. We also use CNTs as vertically aligned nanoneedles and as colloids to efficiently traverse the plasma membrane. While CNTs as nanoneedles show the potential as an efficient means of transfecting mammalian cells, the use of S_SWNTs and US_SWNTs highlight some key observations including the physical and chemical properties (size, surface functionality) and cell type influence on cellular uptake and intracellular trafficking. These findings contribute to the interpretation of SWNT-cell interactions by providing a correlation between CNT length and cellular uptake and also cell type on trafficking of internalized SWNTs. With the realization of the enhanced permeability and retention effects, tumor vascular leakiness resulting from increased angiogenesis and vasoactive factors enhancing permeability at the diseased site, nanoparticles that have long circulation time have higher chance of accumulating at the diseased sites. | en |
dc.description.embargoterms | 1 year | en |
dc.identifier.uri | http://hdl.handle.net/10012/7127 | |
dc.language.iso | en | en |
dc.pending | true | en |
dc.publisher | University of Waterloo | en |
dc.subject | Drug delivery | en |
dc.subject | Cellular uptake of Carbon nanotube | en |
dc.subject.program | Chemistry | en |
dc.title | Carbon Nanotubes as Versatile Devices for Detoxification and Cellular Entry | en |
dc.type | Doctoral Thesis | en |
uws-etd.degree | Doctor of Philosophy | en |
uws-etd.degree.department | Chemistry | en |
uws.peerReviewStatus | Unreviewed | en |
uws.scholarLevel | Graduate | en |
uws.typeOfResource | Text | en |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 256 B
- Format:
- Item-specific license agreed upon to submission
- Description: